Brachytherapy Flashcards

1
Q

Why has brachy changed?

A
  • better technology allows improved tumour control and toxicity
  • safer and more acceptable for patients
  • safer for staff
  • LDR no longer supported
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the levels of dose rate?

A
  • LDR: 0.4-2Gy/hr
  • MDR: 2-12 Gy/hr
  • HDR: > 12 Gy/hr`
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the advantages of HDR?

A
  • outpatient treatment
  • dose optimisation and adaptive planning
  • reduced radiaiton exposure to staff
  • more stable positioning
  • smaller applicators
  • shorter treatment time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the disadvantages of HDR?

A
  • more complex planning and treatment
  • compressed time frame for planning
  • greater potential for error
  • potential for high radiation exposure to staff and patient if source error
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does the source applicator work?

A
  • hollow needle with 7mm dead space at end

- source moves through at different times making the dose distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the definition for high risk CTV?

A
  • residual macroscopic diease at time of brachytherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the definition for intermediate risk CTV?

A
  • intial macroscopic disease at time of diadnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the definition for low risk CTV?

A
  • potential microscopic tumour spread not treated with brachy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When do you image?

A
  • pre treatment
  • during insertion
  • post treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why image pre treatment?

A
  • evaluate tumour
  • determine treatment modality
  • determine treatment volume and dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why image during insertion?

A
  • evaluate tumour response
  • verification of applicator position
  • define CTV and OAR
  • adaptive RT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why image post treatment?

A
  • evaluate tumour response and toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the impact of inter and intrafraction motion?

A
  • more significant for HDR as less fractions
  • steep dose gradient around applicator
  • tumour shrinkage and normal tissue fibrosis may occure over total lenght of time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is dose presribed for brachy?

A
  • point A
  • rectum
  • bladder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the advantages for HDR prostate?

A
  • image guided needle placement
  • optimised dose distribution
  • organ motion minimised
  • radiobiological advantage
  • remote afterloading
  • singel reusable source
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the acute clinical issues for prostate HDR?

A
  • template/catheter movement: minimise movement of patient/bed rest
  • haematuria/clot retention: contionus bladder irrigation
  • perineal discomfort and back discomfort: analgesics
  • infection risk: prohylactic antibiotics
  • DVT prophylaxis: stockings/heparin
  • defaecation: low residue diet prior to and during admission